Lexicon Pharmaceuticals
LXRX
#6318
Rank
NZ$1.74 B
Marketcap
NZ$3.91
Share price
0.86%
Change (1 day)
102.91%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -NZ$45.33 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are NZ$69.64 Million. In 2025 the company made an earning of -NZ$84.21 Million, an increase over its 2024 earnings that were of -NZ$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$45.33 Million-46.18%
2025 -NZ$84.21 Million-74.88%
2024 -NZ$0.34 Billion13.15%
2023 -NZ$0.3 Billion73.74%
2022 -NZ$0.18 Billion16.16%
2021 -NZ$0.15 Billion49.82%
2020 -NZ$97.98 Million-147.19%
2019 NZ$0.20 B-203.42%
2018 -NZ$0.21 Billion-15.31%
2017 -NZ$0.24 Billion0.2%
2016 -NZ$0.24 Billion2920.7%
2015 -NZ$7.84 Million-95.33%
2014 -NZ$0.17 Billion-3.61%
2013 -NZ$0.18 Billion-5.52%
2012 -NZ$0.19 Billion-4.17%
2011 -NZ$0.2 Billion15.5%
2010 -NZ$0.17 Billion8.36%
2009 -NZ$0.16 Billion-4.81%
2008 -NZ$0.17 Billion28.79%
2007 -NZ$0.13 Billion35.71%
2006 -NZ$92.38 Million52.91%
2005 -NZ$60.42 Million-23.89%
2004 -NZ$79.38 Million-24.19%
2003 -NZ$0.11 Billion-0.48%
2002 -NZ$0.11 Billion44.12%
2001 -NZ$73 Million23.01%
2000 -NZ$59.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$12.41 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.94 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.62 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.31 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.13 B-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$38.88 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.64 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$24.96 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA